Implementation strategies of internet-based asthma self-management support in usual care. Study protocol for the IMPASSE cluster randomized trial

Implementation Science

Jacob K Sont³  Bart P Thoonen⁴  Christian Taube¹  Victor van der Meer³  Ad A Kaptein⁵  Willem JJ Assendelft²  Jiska B Snoeck-Stroband³  Leti van Bodegom-Vos³  Moira J Bakker³  Johanna L van Gaalen³ 

[1] Department of Pulmonology, Leiden University Medical Centre, P.O. Box, 9600, 2300, RC, Leiden, the Netherlands;Department of Public health and Primary care, Leiden University Medical Centre, P.O. Box, 9600, 2300, RC, Leiden, the Netherlands;Department of Medical Decision Making, Leiden University Medical Centre, P.O. Box 9600, 2300, RC, Leiden, the Netherlands;Department of General Practice, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500, HB, Nijmegen, the Netherlands;Department of Medical psychology, Leiden University Medical Centre, P.O. Box, 9600, 2300, RC, Leiden, the Netherlands

关键词: Chronic care;    Implementation;    Self-management;    E-health;    Telemanagement;    Self-management;    Asthma;   

Others  :  813867
DOI  :  10.1186/1748-5908-7-113

 received in 2012-10-01, accepted in 2012-11-16,  发布年份 2012

【 摘 要 】

Background

Internet-based self-management (IBSM) support cost-effectively improves asthma control, asthma related quality of life, number of symptom-free days, and lung function in patients with mild to moderate persistent asthma. The current challenge is to implement IBSM in clinical practice.

Methods/design

This study is a three-arm cluster randomized trial with a cluster pre-randomisation design and 12 months follow-up per practice comparing the following three IBSM implementation strategies: minimum strategy (MS): dissemination of the IBSM program; intermediate strategy (IS): MS + start-up support for professionals (i.e., support in selection of the appropriate population and training of professionals); and extended strategy (ES): IS + additional training and ongoing support for professionals. Because the implementation strategies (interventions) are primarily targeted at general practices, randomisation will occur at practice level.

In this study, we aim to evaluate 14 primary care practices per strategy in the Leiden-The Hague region, involving 140 patients per arm. Patients aged 18 to 50 years, with a physician diagnosis of asthma, prescription of inhaled corticosteroids, and/or montelukast for ≥3 months in the previous year are eligible to participate. Primary outcome measures are the proportion of referred patients that participate in IBSM, and the proportion of patients that have clinically relevant improvement in the asthma-related quality of life. The secondary effect measures are clinical outcomes (asthma control, lung function, usage of airway treatment, and presence of exacerbations); self-management related outcomes (health education impact, medication adherence, and illness perceptions); and patient utilities. Process measures are the proportion of practices that participate in IBSM and adherence of professionals to implementation strategies. Cost-effective measurements are medical costs and healthcare consumption. Follow-up is six months per patient.

Discussion

This study provides insight in the amount of support that is required by general practices for cost-effective implementation of IBSM. Additionally, design and results can be beneficial for implementation of other self-management initiatives in clinical practice.

Trial registration

the Netherlands National Trial Register NTR2970

【 授权许可】

   
2012 van Gaalen et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Global Initiative for Asthma(GINA): Global Strategy for Asthma Management and Prevention. NHLBI/WHO workshop report. National Institutes of Health, National Heart, Lung and Blood Institute; 2011. http://www.ginasthma.org webcite], accessed September 2012
• [2]Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, Weiss ST: Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004, 114(1):40-47.
• [3]Thomas M, Kay S, Pike J, Williams A, Rosenzweig JR, Hillyer EV, Price D: The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Prim Care Respir J 2009, 18(1):41-49.
• [4]Gibson PG, Coughlan J, Wilson AJ, Abramson M, Bauman A, Hensley MJ, Walters EH: Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003, (1):CD001117.
• [5]Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J: Self-management approaches for people with chronic conditions: a review. Patient Educ Couns 2002, 48(2):177-187.
• [6]Ring N, Malcolm C, Wyke S, Macgillivray S, Dixon D, Hoskins G, Pinnock H, Sheikh A: Promoting the use of personal asthma action plans: a systematic review. Prim Care Respir J 2007, 16(5):271-283.
• [7]Jones A, Pill R, Adams S: Qualitative study of views of health professionals and patients on guided self management plans for asthma. BMJ 2000, 321(7275):1507-1510.
• [8]Hoskins G, McCowan C, Donnan PT, Friend JA, Osman LM: Results of a national asthma campaign survey of primary care in Scotland. Int J Qual Health Care 2005, 17(3):209-215.
• [9]Australian Centre for Asthma Monitoring: Asthma in Australia 2011. Asthma series no.4. 2011. http://www.aihw.gov.au/ webcite], accessed September 2012
• [10]Finkelstein J, Friedman RH: Potential role of telecommunication technologies in the management of chronic health conditions. Dis Manag Health Out 2000, 8:57-63.
• [11]Giordano A, Scalvini S, Zanelli E, Corra U, Longobardi GL, Ricci VA, Baiardi P, Glisenti F: Multicenter randomised trial on home-based telemanagement to prevent hospital readmission of patients with chronic heart failure. Int J Cardiol 2009, 131(2):192-199.
• [12]Ruehlman LS, Karoly P, Enders C: A randomized controlled evaluation of an online chronic pain self management program. Pain 2011, 153(2):319-330.
• [13]Miller EA: Solving the disjuncture between research and practice: telehealth trends in the 21st century. Health Policy 2007, 82(2):133-141.
• [14]McLean S, Chandler D, Nurmatov U, Liu J, Pagliari C, Car J, Sheikh A: Telehealthcare for asthma: a Cochrane review. Can Med Assoc J 2011, 183(11):E733-E742.
• [15]Braunstein ML: Telemanagement--the third wave of telecare. Caring 2007, 26(7):8-10. 12–14
• [16]Van der Meer V, Bakker MJ, van den Hout WB, Rabe KF, Sterk PJ, Kievit J, Assendelft WJ, Sont JK: Internet-based self-management plus education compared with usual care in asthma: a randomized trial. Ann Intern Med 2009, 151(2):110-120.
• [17]Van der Meer V, van den Hout WB, Bakker MJ, Rabe KF, Sterk PJ, Assendelft WJ, Kievit J, Sont JK: Cost-effectiveness of internet-based self-management compared with usual care in asthma. PLoS One 2011, 6(11):e27108.
• [18]Schouten JA, Hulscher ME, Trap-Liefers J, Akkermans RP, Kullberg BJ, Grol RP, van der Meer JW: Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial. Clin Infect Dis 2007, 44(7):931-941.
• [19]Thoonen BP, Schermer TR, Akkermans RP, den Otter JJ, Grol R, van Schayck OC: Willingness of patients to perform self-management of asthma and the role of inhaled steroids. Scand J Prim Health Care 2002, 20(1):60-64.
• [20]Van der Meer V, van Stel HF, Bakker MJ, Roldaan AC, Assendelft WJ, Sterk PJ, Rabe KF, Sont JK: Weekly self-monitoring and treatment adjustment benefit patients with partly controlled and uncontrolled asthma: an analysis of the SMASHING study. Respir Res 2010, 11:74. BioMed Central Full Text
• [21]Prior M, Guerin M, Grimmer-Somers K: The effectiveness of clinical guideline implementation strategies–a synthesis of systematic review findings. J Eval Clin Pract 2008, 14(5):888-897.
• [22]Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR: Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999, 282(15):1458-1465.
• [23]Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, Whitty P, Eccles MP, Matowe L, Shirran L, et al.: Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004, 8(6):iii-iv. 1–72
• [24]Grol R, Grimshaw J: From best evidence to best practice: effective implementation of change in patients’ care. Lancet 2003, 362(9391):1225-1230.
• [25]Grol R, Wensing M: What drives change? Barriers to and incentives for achieving evidence-based practice. Med J Aust 2004, 180(6 Suppl):S57-S60.
• [26]Van Gaalen JL, Snoeck-Stroband JB, Vos L, Bakekr MJ, Kaptein AA, Assendelft WJJ, Willems LNA, Thoonen BPA, Sont JK: Internet-based self-management (IBSM) in asthma, from evidence to practice: A qualitative study of barriers and facilitators for implementation [abstract]. Eur Respir J 2011, 38(Suppl 55):568-569.
• [27]Campbell MK, Piaggio G, Elbourne DR, Altman DG: Consort 2010 statement: extension to cluster randomised trials. BMJ 2012, 345:e5661.
• [28]Juniper EF: Assessing asthma control. Curr Allergy Asthma Rep 2007, 7(5):390-394.
• [29]Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR: Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999, 14(4):902-907.
• [30]Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR: Validation of a standardized version of the asthma quality of life questionnaire. Chest 1999, 115(5):1265-1270.
• [31]Dolan P: Modeling valuations for EuroQol health states. Med Care 1997, 35(11):1095-1108.
• [32]Fialko L, Garety PA, Kuipers E, Dunn G, Bebbington PE, Fowler D, Freeman D: A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophr Res 2008, 100(1–3):53-59.
• [33]Broadbent E, Petrie KJ, Main J, Weinman J: The brief illness perception questionnaire. J Psychosom Res 2006, 60(6):631-637.
• [34]van den Hout WB, Tijhuis GJ, Hazes JM, Breedveld FC, Vliet Vlieland TP: Cost effectiveness and cost utility analysis of multidisciplinary care in patients with rheumatoid arthritis: a randomised comparison of clinical nurse specialist care, inpatient team care, and day patient team care. Ann Rheum Dis 2003, 62(4):308-315.
• [35]Geijer RMM, Chavannes NH, Muris JWM, Sachs APE, Schermer TR, Smeele IJM, Thoonen B, Van der Molen T, Van Schayck CP, Van Weel C, et al.: NHG standaard Astma bij volwassenen. Huisarts Wet 2007, 50:537-551.
• [36]Creer TL: Behavioral and cognitive processes in the self-management of asthma. J Asthma 2008, 45(2):81-94.
• [37]Kaptein AA, Klok T, Moss-Morris R, Brand PL: Illness perceptions: impact on self-management and control in asthma. Curr Opin Allergy Clin Immunol 2010, 10(3):194-199.
• [38]Clatworthy J, Price D, Ryan D, Haughney J, Horne R: The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J 2009, 18(4):300-305.
• [39]Wensing M, Bosch M, Grol R: Developing and selecting interventions for translating knowledge to action. CMAJ 2010, 182(2):E85-88.
• [40]Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, et al.: An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009, 180(1):59-99.
• [41]Osborne RH, Elsworth GR, Whitfield K: The Health Education Impact Questionnaire (heiQ): an outcomes and evaluation measure for patient education and self-management interventions for people with chronic conditions. Patient Educ Couns 2007, 66(2):192-201.
• [42]Young TA, Yang Y, Brazier JE, Tsuchiya A: The use of rasch analysis in reducing a large condition-specific instrument for preference valuation: the case of moving from AQLQ to AQL-5D. Med Decis Making 2011, 31(1):195-210.
• [43]Szende A, Svensson K, Stahl E, Meszaros A, Berta GY: Psychometric and utility-based measures of health status of asthmatic patients with different disease control level. Pharmacoeconomics 2004, 22(8):537-547.
• [44]van den Brink M, van den Hout WB, Stiggelbout AM, van de Velde CJ, Kievit J: Cost measurement in economic evaluations of health care: whom to ask? Med Care 2004, 42(8):740-746.
• [45]Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 2006, 15(10):1121-1132.
• [46]Willan AR, Lin DY: Incremental net benefit in randomized clinical trials. Stat Med 2001, 20(11):1563-1574.
• [47]Oostenbrink JB, Koopmanschap MA, Rutten FF: Standardisation of costs: the Dutch manual for costing in economic evaluations. Pharmacoeconomics 2002, 20(7):443-454.
• [48]van Peperstraten A, Nelen W, Grol R, Zielhuis G, Adang E, Stalmeier P, Hermens R, Kremer J: The effect of a multifaceted empowerment strategy on decision making about the number of embryos transferred in in vitro fertilisation: randomised controlled trial. BMJ 2010, 341:c2501.